NCT06355973

Brief Summary

This is to find out the effectiveness of cognitive and physical function training for patients with mild cognitive impairment. It is for the prevention and treatment of dementia in the future. randomized, Pilot Study.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

March 19, 2024

Last Update Submit

April 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Montreal Cognitive Assessment (MoCA)

    K-MoCA is a measure of memory loss or other symptoms of cognitive decline. It includes 30 questions and a task that takes about 12 minutes to complete. The score can range from 0 to 30. A score of 26 or higher is considered normal.

    screening - 6 weeks - 3 months

Secondary Outcomes (9)

  • Korean-Mini Mental Status Examination (K-MMSE)

    Baseline - 6 weeks - 3months

  • Clinical Dementia Rating (CDR)

    Baseline - 3months

  • Clinical Global Impressions of Change (CGIC)

    Baseline - 6 weeks- 3months

  • Instrumental Activities of Daily Living (I-ADL)

    Baseline - 6 weeks- 3months

  • Berg Balance Scale (BBS)

    Baseline - 6 weeks- 3months

  • +4 more secondary outcomes

Study Arms (2)

Using tablets and workbooks.

EXPERIMENTAL

Using tablets and workbooks Cognitive and physical function training self-programming for 6 weeks.

Device: Using tablets and workbooks cognitive function.Device: self-programming of physical function training.

Only self-programming of physical function training.

EXPERIMENTAL

Only self-programming of physical function training is provided Implemented for 6 weeks.

Device: self-programming of physical function training.

Interventions

Cognitive training programs corresponding to memory, attention, time and space, and orientation are conducted for 35 to 60 minutes.

Using tablets and workbooks.

The fitness program consisting of stretching, muscle strength, coordination, and aerobic exercise lasts 20 to 30 minutes, and additional 3-4 times/mainly 30 to 40 minutes of aerobic exercise.

Only self-programming of physical function training.Using tablets and workbooks.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men and women aged 60 or older
  • A person who falls within the abnormal range of the Montreal Cognitive Assessment (MoCA) test
  • a person who can independently carry out daily life
  • If the subject or legal representative voluntarily decides to participate and agrees in writing to comply with the precautions after hearing and fully understanding the detailed explanation of this clinical study

You may not qualify if:

  • A person diagnosed with Alzheimer's dementia or other causes (stroke, brain tumor, cerebral palsy, dementia, Parkinson's disease, etc.)
  • A person with unstable cardiovascular system, digestive system, respiratory system, endocrine system, etc. and poor general condition
  • Patients who have participated in other treatment clinical studies or who have participated in other treatment clinical studies within the last 30 days
  • Other cases where the researcher determines that participation in this clinical study is not appropriate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • MinYoung Kim, MD, PhD

    CHA Bundang Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MinYoung Kim, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

March 19, 2024

First Posted

April 10, 2024

Study Start

April 1, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 10, 2024

Record last verified: 2024-04